F18.180
Inhalant abuse with inhalant-induced anxiety disorder
Clinical Classification Guidelines
Medical Intelligence & Overview
ICD-10 Code F18.180 refers to a condition where an individual abuses inhalants, substances that are inhaled to achieve a high, and concurrently experiences an anxiety disorder caused by the inhalant use. This dual diagnosis highlights the complex relationship between substance abuse and mental health, emphasizing the need for comprehensive treatment approaches. Inhalant abuse, especially when linked to anxiety disorder, requires understanding the reasons behind the misuse and the emotional symptoms it produces to better manage and prevent serious health complications.
Causes & Symptoms
Clinical Causes: Peer pressure or social influence encouraging inhalant use Curiosity about psychoactive effects, especially in adolescents Attempting to self-medicate anxiety, depression, or other mental health issues Accessibility to inhalants like glue, paint fumes, aerosols, or inhalation sprays Presence of underlying psychological conditions that predispose to substance misuse Environmental factors such as stress, trauma, or family dysfunction
Key Symptoms: Intoxication signs such as dizziness, slurred speech, or lack of coordination Persistent anxiety, panic attacks, or agitation following inhalant use Dependence characterized by craving or inability to stop inhalant use Memory problems and difficulty concentrating Changes in behavior, including irritability and social withdrawal Physical signs like nausea, headache, or chemical odor on breath and clothing Emotional symptoms such as heightened fear or persistent worry
Diagnostic & Treatment
Diagnosis Path: Diagnosis involves a comprehensive medical and psychological assessment. Healthcare providers review the individual's inhalant use history and observe physical symptoms. Mental health evaluations help identify co-occurring anxiety disorders. Laboratory tests, including blood and urine screens, may detect inhalant metabolites. The clinician also rules out other causes for anxiety symptoms, ensuring an accurate diagnosis of inhalant-induced anxiety disorder associated with substance abuse.
Treatment Protocols: Detoxification and medical management to safely cease inhalant use Psychotherapy such as cognitive-behavioral therapy (CBT) to develop coping skills and manage anxiety Counseling and support groups to promote emotional recovery and prevent relapse Medication in some cases to ease anxiety symptoms or treat underlying mental health issues Development of healthy routines and social support networks to reduce reliance on inhalants Educational interventions to inform about the risks associated with inhalant abuse
Clinical Advice & FAQs
Billing Guidance
Is F18.180 a billable ICD-10 code?
Yes, F18.180 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report F18.180?
Clinical documentation must specify the nature of Inhalant abuse with inhalant-induced anxiety disorder and any associated comorbidities for accurate reporting.
Cite this Clinical Reference